|
 |
 |
 |
 |
Name:
Sector:
Chief Executive:
|
Human Genome Sciences
Healthcare
H. Thomas Watkins
|
 |
Summary:
|
Researches and develops novel compounds for treating and diagnosing
human diseases based on the discovery and understanding of the
medical usefulness of genes.
|
 |
Stage of Initial
Investment:
|
Seed/Early |
Liquidity:
|
IPO
(NASDAQ: HGSI)
|
 |
 |
 |
 |
|
|
 |
 |
14200 Shady Grove Road
Rockville, MD 20850-3338
Phone: 301.309.8504
Fax: 301.309.8512 |
 |
 |
|
|
|